New Jersey pharma firm sees stocks fall - - ModernMedicine

New Jersey pharma firm sees stocks fall
Publish date: Dec 1, 2009
By:  Bill Gillette
Source: Dermatology Times E-News

Berkeley Heights, N.J. — Pharmaceutical company Genta Inc., based here, announced recently that a phase 3 drug trial for the melanoma drug Genasense showed no statistically significant benefit compared with a placebo, reports news source Foxbusiness.com.

Genta stock shares fell by more than 11 percent following the announcement.

The company also announced plans to cut staff by about 30 percent, adding that the cost savings should be enough to provide cash sufficient for continued operations into the second quarter of 2010.

post a comment
Please complete the form below to post your comment.
Bold = Required
Email Address Your email address will NOT be published.
Display Name appears with your comment
City
State
Country
Remember me: YesNo
Comment read our privacy policy
Note: does not support HTML
All comments submitted are subject to review and may be delayed before posting. We reserve the right not to post comments. Comments from patients or members of patients' families seeking medical advice will not be posted.
eSamples check closet
eSamples check closet
Featured Jobs

More Jobs

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Dermatology Diagnosis
Dermatology Diagnosis

Identify skin diseases by age, gender, location. Start Here

AHRQ Clinical Guidelines
AHRQ Clinical Guidelines

Objective findings on medical interventions. Start Here

Clinical Perspectives
AcneAdolescent MedicineAllergy & ImmunologyAlzheimer's DiseaseAsthmaBPHBreast CancerCardiologyCataractsChild Behavior & DevelopmentClinical PharmacologyContraceptionCorneal DiseaseCosmetic DermatologyCosmetic SurgeryDepressionDermatologyDiabetesDry EyeEczema/Atopic DermatitisEndocrinologyEpilepsyErectile DysfunctionGastroenterologyGastroesophageal Reflux Disease (GERD) & Acid Peptic DiseaseGeriatricsGlaucomaGynecologic OncologyHIV/AIDSHormone TherapyHyperlipidemiaHypertensionImmunization/VaccinesInfectious DiseaseInternal MedicineIrritable Bowel Syndrome (IBS)Kidney & Bladder CancerLaser & Light Technology in DermatologyMaternal & Fetal MedicineMenopauseMigraineMultiple SclerosisNeurologyNutritionOb/Gyn SurgeryObesityOB/GYN & Women's HealthOncologyOphthalmologyOptometryOrthopedicsOsteoporosisParkinson's DiseasePathologyPediatricsPrimary Care MedicineProstate CancerPsoriasisPsychiatry & Behavioral HealthRadiologyRefractive Surgery Reproductive Endocrinology/InfertilityRetinal DiseaseRheumatoid ArthritisSkin CancerSleep DisordersSmoking-Related IllnessStrokeSurgeryUrinary Incontinence/Overactive BladderUrologic SurgeryUrology
Business Perspectives
Coding CounselorLiability & Risk ManagementHealth Care Information TechnologyPractice ManagementBusiness OperationsHuman ResourcesHealth Law & PolicyManaged CarePersonal FinanceProducts
Popular Topics
CME/CECoding CounselorEczema: Emollients, Counseling, and CareFind Resources to Help Manage Plaque Psoriasis Effectively [SPONSORED]Oral Anticoagulation in Atrial FibrillationEHR Technology eNewslettersGERD Resources for Your Practice and Patients [SPONSORED]Find Resources to Help Inform Patients on Managing Their IOP [SPONSORED]Find Resources to Help with Cataract Procedures [SPONSORED]Learn about Wavefront Technology in Progressive Lenses [SPONSORED]Help Prevent SREs in Your Patients with Bone Metastases [SPONSORED]Rx Adherence ToolAHA 2010 Video ReportsSurgery as Early Intervention in Morbid ObesityPatient Education CenterFracture Risk in Postmenopausal WomenBlogsSpecial Reports from The National Center for Children in Poverty (NCCP) DiscussionsModernMedicine RadioClinical Reference ManualsSyndicationSurgical Video Center
Source: Dermatology Times E-News, 12/1/2009
Click here